Introduction
============

It has long been known that patients subjected to organ replacement exhibit disruptions in blood pressure diurnal variations. This is mainly related to the absence of a nocturnal decrease in blood pressure, that has been found to be a predictor of hypertension and several chronic cardiopathies (Lipkin et al., [@B22]; van de Borne et al., [@B38]; Textor et al., [@B37]; Taler et al., [@B36], [@B35]; van den Dorpel et al., [@B39]; Galiatsou et al., [@B8]; Curtis, [@B5]). Sleep disturbances are also very frequent in these patients, strongly affecting their quality of life (Neuhaus et al., [@B27]; Kemper et al., [@B20]). However, the mechanisms underlying these temporal disturbances have not been elucidated (van de Borne et al., [@B38]; Textor et al., [@B37]; Taler et al., [@B36]; van den Dorpel et al., [@B39]; Kooman et al., [@B21]; Curtis, [@B5]). Indeed, the control of the 24-h variation of blood pressure is complex and, in some cases, controversial, since it is modulated by both endogenous and exogenous cues (Halberg et al., [@B9]; Degaute et al., [@B6]; Portaluppi et al., [@B31]; Witte et al., [@B40]), and influenced by other physiological and pathological variables like normal and pathological sleep (Smolensky et al., [@B33]), including obstructive sleep apnea syndrome (Lusardi et al., [@B23]; Kario, [@B18]) and neuroendocrine parameters such as cortisol, sympathetic mediators, and the renin--angiotensin--aldosterone system, all of which are indeed modulated by the circadian clock (Holt-Lunstad and Steffen, [@B14]; Rudic and Fulton, [@B32]). In addition, humoral factors that affect blood pressure directly, such as renin, are also dependent on sleep stages (Brandenberger et al., [@B2]).

Although an accurate description of these temporal disruptions is necessary in order to determine worthwhile associations, not all of the data have been analyzed with specific chronobiological tools. Sleep disturbances have been studied with *ad-hoc* questionnaires and the daily rhythm of blood pressure and heart rate have been analyzed following the standard classification of dippers/non-dippers (D/ND). This classification, defined as a difference between diurnal and nocturnal average levels of more or less than 10%, respectively, does not consider transitional periods between low and high blood pressure stages, confidence intervals, changes in the waveform or shifts in the phase of blood pressure rhythm. Moreover, it does not analyze diurnal and nocturnal values with precision as a result of a subjective definition of day and night onsets (Parati, [@B29]).

The non-symmetrical double-logistic fitting procedure for modeling 24-h blood pressure variation (Head et al., [@B11]) is based on the assumption that transitions between lower and higher levels of blood pressure are not abrupt and symmetrical, and are independent from subjective definitions of awake and asleep stages. This method has been clearly validated in a number of physiological and pathological situations (Head et al., [@B12], [@B13], [@B10]). In order to perform a more detailed analysis of the daily disruptions in blood pressure in renal transplant recipients, we have performed a retrospective study to apply this double-logistic fitting to 24-h blood pressure recordings of a group of patients subjected to kidney replacement, as compared to a group of subjects matched by age, sex, and the average of 24-h mean arterial pressure (MAP). In addition, we have also applied the Cosinor method, which determines the best-fitting cosine waveform to the data in terms of period, amplitude, and time of peak (acrophase) (Nelson et al., [@B25]; Bingham et al., [@B1]; Mohri et al., [@B24]). We also analyzed the associations of daily disruptions with pharmacological and physiological parameters.

Materials and Methods
=====================

Patients
--------

In this retrospective study, the ambulatory blood pressure monitoring (ABPM) data of adult renal transplant recipients was analyzed in order to assess their 24 h profile. Patients diagnosed with any cardiovascular disease other than hypertension, with neurological or psychiatric diseases, night workers, and those with sleep complaints, were excluded from the study. Twenty-four-hour records with more than one-third of data absent were not used for analysis. Forty-one renal transplant recipients were included, all of them were receiving oral treatment with CsA and meprednisone, 34 patients were also receiving mycophenolate mofetil, while the remaining 7 were on azathioprine treatment; 27 were hypertensive according to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7; Jones and Hall, [@B17]) and were receiving antihypertensive drugs. For the control group, 41 non-transplanted individuals that were receiving medical attention at the Internal Medicine department of the same hospital were enrolled in the study, matched by sex, age, and the average of 24 h MBP (24 MAP-av), with the same exclusion criteria. All the individuals' filiation data included in the study were blind for the researchers that performed the analysis. Informed consent was obtained from all subjects. The ethics committees of the University of Quilmes, Buenos Aires, Argentina and the Dr. Cosme Argerich Hospital, Buenos Aires, Argentina, approved the study.

Ambulatory blood pressure monitoring
------------------------------------

Ambulatory blood pressure monitoring was recorded non-invasively over 24 h on a regular working day with an Accutraker II (Suntech Medical Inc., NC, USA) with the cuff placed in the arm without arteriovenous fistula. Recordings were made every 15 min during daytime (08:00 a.m. to 11:00 p.m.) and every 20 min during the night (11:00 p.m. to 08:00 a.m.). Individualized analysis of ambulatory blood pressure profiles was performed by adjusting readings according to the awake/asleep written report of each participant, who were instructed to sleep at their usual time (sleep onset 09.00 to 11.00 p.m.). The average 24 h, awake and asleep blood pressures were also recorded.

Measurements of serum creatinine, creatinine clearance, and serum cyclosporin
-----------------------------------------------------------------------------

Data was collected on the day of the blood pressure monitoring during the morning, before breakfast, and before the morning dose of CsA (*T*~0~). The Jaffé method was used for measurement of both serum and urinary creatinine. Creatinine clearance was calculated by the formula *U*/*S* × urine flow (*U* = urinary creatinine concentration, *S* = serum creatinine concentration). Serum CsA was measured by a fluorescence polarization immunoassay (Abbott Laboratories, IL, USA).

Modeling of 24-h profile of blood pressure
------------------------------------------

The *double-logistic method* was applied as described (Head et al., [@B11]). This model considers a stage of high level of blood pressure, named *high plateau*, a stage of low level of blood pressure, named *low plateau*, the range of the variation, quantified as the difference between high and low plateaus, and two transitional stages modeled logistically. These transitional stages are calculated independently, relating to separate ascending and descending parameters. The time of each transition corresponds to the time when the curve reaches the 50% of its final value (Figure [1](#F1){ref-type="fig"}). This method also calculates the slope of the variation. Fittings with a *p* value \> 0.05 were considered as non-statistically significant and therefore without daily variation. The parameters defined by the model were analyzed only in individuals with significant daily variation. In Table [2](#T2){ref-type="table"}, time of transition stages are shown in numerical format (100 decimals = 60 min).

![**Individual examples of the modeling procedures in both groups**. The upper plot corresponds to a control individual and the lower plot to a renal transplant recipient. Double-logistic fitting is plotted with solid line and Cosinor fitting with dash--dot line. Black filled triangles are SAP hourly values and white filled triangles DAP values.](fneur-03-00035-g001){#F1}

The *Cosinor analysis* was performed as described previously (Nelson et al., [@B25]; Bingham et al., [@B1]; Mohri et al., [@B24]). This method consists of adjusting the best least-squares fitting cosine waveform to the data according to the equation *y* = *M* + *A* cos (*f* + ω*t*), in which *M* corresponds to mesor (*mean estimated over rhythm*), *A* is the amplitude which is defined as the value that corresponds to half of the difference between the maximum--minimum values of the adjusted curve, *t* is time, ω is angular velocity that, in a 24-h-period rhythm, corresponds to 2π/24 = 0,2618 radians/h (with time expressed in hours), and *f* represents the acrophase (time of peak) which is converted into hours dividing it by ω. Waveform fittings with a *p* value \> 0.05 were considered as non-statistically significant and therefore without daily variation. Amplitude and acrophase were analyzed only in individuals with significant daily variation (Figure [1](#F1){ref-type="fig"}). In Table [3](#T3){ref-type="table"}, acrophase is showed in numerical format (100 decimals = 60 min).

Statistical analysis
--------------------

Data were averaged into 1 h bins for smoothing of serial recordings (sampling frequency was different between day and night). All comparisons of proportions (like analysis of fitting-related variables in patients with or without hypertension) were made with Fisher's exact test. Differences between groups were analyzed with either Student's, Welsh's, or Mann--Whitney's test according to the assessment of normality distribution of data which was measured with the combination of Shapiro--Wilk test and the visual examination of Normality and Box plots by at least two observers, and the comparison of SDs with F test when appropriate. Differences in the distribution of data (variances) were analyzed with the Modified Levene's test (Neter et al., [@B26]). Since most of numerical comparison were performed with non-parametric tests, the data is presented as median (first quartile; third quartile) in all cases, for homogenization. Differences were considered as statistically significant when *p* \< 0.05.

Results
=======

The most relevant characteristics of both groups are summarized in Table [1](#T1){ref-type="table"}.

###### 

**Characteristics of renal transplant recipients and controls**.

                                            Renal transplant recipients     Controls
  ----------------------------------------- ------------------------------- --------------------------------
  Number of subjects                        41                              41
  Sex, female/male                          17/24                           17/24
  Age, years                                43 (18; 32; 50; 69)             42 (20; 32; 50; 69)
  Average of 24 h MAP, mmHg                 101 (78.7; 93.8; 109.3; 132)    100.7 (79; 93.3; 108.1; 134.7)
  TESS, months                              26 (2; 7.5; 59; 192)            
  Cyclosporin                                                               
        Oral dose, mg/kg                    2.77 (0.81; 1.86; 3,54; 5.32)   
        Serum concentration,                144 (25; 103; 176; 259)         
        ng/dl                                                               
  Meprednisone, mg/kg                       0.09 (0.04; 0.06; 0,12; 0.34)   
  Mycophenolate mofetil, mg/kg (*n* = 34)   28.1 (13.3; 24.7; 32.9; 42.5)   
  Azathioprine, mg/kg (*n* = 7)             1.1 (0.72; 0.82; 1.26; 1.35)    

*Data is presented as median (minimum; first quartile; third quartile; maximum) except for number of subjects and sex. MBP, mean blood pressure; TESS, time elapsed since date of surgery*.

Presence of a daily variation according to the double-logistic method
---------------------------------------------------------------------

To assess the presence of a daily rhythm in 24-h blood pressure variations, we compared the proportion of individuals whose double-logistic fitting of 24-h blood pressure profile reached statistical significance. Differences between patients and controls were significant for systolic arterial pressure (SAP), with a lower proportion of renal transplant recipients showing statistically significant rhythms, but did not reach significance for diastolic arterial pressure (DAP) or MAP (Table [2](#T2){ref-type="table"}).

###### 

**Comparison of parameters analyzed by double-logistic method between renal transplant recipients and controls**.

                                              Kidney recipients      Controls               *p* Groups     *p* Variances
  ------------------------------------------- ---------------------- ---------------------- -------------- ---------------
  **SYSTOLIC ARTERIAL PRESSURE**                                                                           
  No. of significant daily rhythm/total (%)   23/41 (56.1%)          33/41 (80.5%)          \<0.05\*       
  High plateau, mmHg                          145.3 (136.0; 156.6)   136.3 (129.9; 144.5)   \<0.05\*\*     
  Low plateau, mmHg                           119.4 (113.1; 126.0)   103.2 (97.9; 115.7)    \<0.01\*\*\*   
  Difference between high and low BP, mmHg    25 (19.3; 33.5)        29.3 (22.7; 34.0)      NS\*\*\*       
  Transition rate                                                                                          
        Low to high BP                        8.7 (4.33; 28.62)      21.7 (6.3; 53.2)       NS^†^          
        High to low BP                        −6.8 (−21.4; −4.9)     −16.6 (−33.0; −8.0)    NS^†^          
  Transition time, hours                                                                                   
        Low to high BP                        9.48 (6.6; 14.4)       7.7 (6.4; 9.1)         NS^†^          \<0.001^‡^
        High to low BP                        23.9 (22.2; 1.9)       23.7 (22.7; 0.8)       NS^†^          \<0.01^‡^
  **DIASTOLIC ARTERIAL PRESSURE**                                                                          
  No. of significant daily rhythm/total (%)   26/41 (63.4%)          33/41 (80.5%)          NS\*           
  High plateau, mmHg                          92.7 (86.7; 100.7)     89.7 (82.2; 96.8)      NS\*\*         
  Low plateau, mmHg                           72.7 (64.3; 77.9)      65.5 (62.4; 71.0)      \<0.01\*\*\*   
  Difference between high and low BP, mmHg    19.0 (15.3; 24.0)      21.9 (18.8; 28.3)      NS^†^          
  Transition rate                                                                                          
        Low to high BP                        8.0 (4.5; 20.9)        19.2 (6.5; 34.35)      NS^†^          
        High to low BP                        −8.9 (−29.6; −2.8)     −10.1 (−18.5; −2.64)   NS^†^          
  Transition time, hours                                                                                   
        Low to high BP                        8.9 (6.8; 10.6)        7.4 (6.5; 8.3)         \<0.05^†^      NS^‡^
        High to low BP                        21.6 (19.2; 23.8)      22.9 (21.6; 1.0)       NS^†^          \<0.01^‡^
  **MEAN BLOOD PRESSURE**                                                                                  
  No. of significant daily rhythm/total (%)   25/41 (61.0%)          31/41 (75.6%)          NS\*           
  High plateau, mmHg                          109.1 (101.5; 118.4)   103.0 (98.0; 110.3)    NS\*\*\*       
  Low plateau, mmHg                           85.7 (81.0; 93.6)      79.9 (74.5; 86.0)      \<0.05\*\*     
  Difference between high and low BP, mmHg    17.7 (14.7; 24.5)      22.2 (19.5; 26.3)      NS^†^          
  Transition rate                                                                                          
        Low to high BP                        6.4 (4.7; 28.9)        24.9 (10.3; 43.4)      \<0.05^†^      
        High to low BP                        −8.2 (−16.7; −4.8)     −10.9 (−27.2; −6.4)    NS^†^          
  Transition time, hours                                                                                   
        Low to high BP                        8.2 (6.6; 11.8)        7.4 (6.7; 8.2)         NS^†^          \<0.05^‡^
        High to low BP                        23.2 (21.2; 0.7)       23.4 (22.5; 0.7)       NS^†^          \<0.01^‡^

*Data is presented as median (first quartile; third quartile) except for number/percentage of subjects with significant daily rhythms. Time of transition stages is shown in numerical format (100 decimals = 60 min). The *n* per group corresponds to the number of individuals with significant daily rhythm. \*Fisher's exact test, \*\*Welsh's test, \*\*\*Student's test, ^†^Mann--Whitney test, ^‡^Modified Levene's test. BP, blood pressure; NS, not statistically significant*.

Differences in parameters analyzed by the double-logistic method
----------------------------------------------------------------

In order to analyze the characteristics of 24-h variations we compared statistically significant double-logistic fittings between renal transplant recipients and controls regarding the six parameters defined from the model. Renal transplant recipients exhibited increased levels of low plateaus for SAP, DAP and MAP, and of high plateau only in SAP. However, the amplitude of the daily variation remained unchanged for the three parameters (Table [2](#T2){ref-type="table"}).

The analysis of the steepness of transition between high and low blood pressure plateaus showed that the rate (slope) of increase in MAP was slower for renal transplant recipients. Transition from high to low plateau remained unchanged.

In the case of the times when transitional periods occur, we found a significantly wider distribution along the 24-h for SAP and MAP ascending stage (Table [2](#T2){ref-type="table"}; Figure [2](#F2){ref-type="fig"}). The same wider distribution was found for the time when SAP, DAP, and MAP descending stages occurred (Table [2](#T2){ref-type="table"}; Figure [3](#F3){ref-type="fig"}). Indeed, in the representative examples of Figure [1](#F1){ref-type="fig"} we chose to depict one of the patients that exhibited an inversion in the timing of blood pressure rhythms.

![**Histograms showing the distribution of the times when transition from low to high blood pressure stages occur for SAP, DAP, and MAP in renal transplant recipients and controls**.](fneur-03-00035-g002){#F2}

![**Histograms showing the distribution of the times when transition from high to low blood pressure stages occur for SAP, DAP, and MAP in renal transplant recipients and controls**.](fneur-03-00035-g003){#F3}

The non-parametrical comparison showed also that the time of DAP ascending occurred later in renal transplant patients

Since the time of transition is related to the phase of blood pressure rhythms, we performed the Cosinor analysis to confirm this phase-related disorder.

Cosinor analysis
----------------

Although in all cases the proportion of individuals with a significant daily variation according to Cosinor analysis was higher for controls, the differences found in SBP, DBP, and MBP did not reach statistical significance (Table [3](#T3){ref-type="table"}). However, renal transplant recipients exhibited a significantly lower amplitude of their SBP and MBP rhythms (Table [3](#T3){ref-type="table"}). As suggested by double-logistic fitting, the analysis of the acrophase, which reflects the phase of a daily variation, showed that its distribution along the 24-h is clearly narrower in the control group than in renal transplant recipients, who exhibited a significantly higher variance in the peak times of SBP, DBP, and MBP (Table [3](#T3){ref-type="table"}).

###### 

**Comparison of parameters analyzed by Cosinor method between renal transplant recipients and controls**.

                                              Kidney recipients   Controls            *p* Groups   *p* Variances
  ------------------------------------------- ------------------- ------------------- ------------ ---------------
  **SYSTOLIC ARTERIAL PRESSURE**                                                                   
  No. of significant daily rhythm/total (%)   27/41 (65.9%)       29/41 (70.7%)       NS\*         
  Amplitude, mmHg                             10.1 (8.3; 12.9)    15.8 (11.0; 17.4)   \<0.05\*\*   
  Acrophase, hours                            15.6 (13.9; 20.2)   15.5 (14.4; 16.7)   NS\*\*       \<0.01\*\*\*
  **DIASTOLIC ARTERIAL PRESSURE**                                                                  
  No. of significant daily rhythm/total (%)   26/41 (63.4%)       33/41 (80.5%)       NS\*         
  Amplitude, mmHg                             8.4 (6.4; 11.4)     9.9 (7.8; 12.3)     NS\*\*       
  Acrophase, hours                            14.4 (13.3; 17.5)   14.9 (14.2; 16.1)   NS\*\*       \<0.05\*\*\*
  **MEAN BLOOD PRESSURE**                                                                          
  No. of significant daily rhythm/total (%)   27/41 (65.9%)       34/41 (82.9%)       NS\*         
  Amplitude, mmHg                             8.2 (6.1; 9.8)      10.4 (7.7; 12.8)    \<0.05\*\*   
  Acrophase, hours                            14.8 (13.4; 17.8)   15.1 (14.2; 16.3)   NS\*\*       \<0.05\*\*\*

*Data is presented as median (first quartile; third quartile) except for the percentage of subjects with significant daily rhythms. Acrophase is shown in numerical format (100 decimals = 60 min). The *n* per group corresponds to the number of individuals with significant daily rhythm. \*Fisher's exact test, \*\*Mann--Whitney's test, \*\*\*modified Levene's test. NS, not statistically significant*.

Association analysis of the diurnal profile of blood pressure in renal transplant recipients
--------------------------------------------------------------------------------------------

In order to explain the disruptions found in double-logistic fitting-related parameters in renal transplant recipients, we analyzed the association between them and several variables. We divided the kidney recipients group according to the level of oral dose of CsA, serum concentration of CsA, oral dose of meprednisone, treatment with either mycophenolate mofetil or azathioprine, the time elapsed since the date of the transplant to the date of the study, serum concentration and clearance of creatinine, age, and the average of the 24-MBP-av. An additional subdivision for the analysis relied on whether patients had been diagnosed with hypertension or not. In numerical variables we used the median of each variable as the cut-of value to generate high and low level sub-groups. We could not find any significant association. Multivariate analysis could not be performed because of the absence of variables that reached an association with a *p* value less than 0.10.

Discussion
==========

Given the extensive description of disruptions in day/night blood pressure variation in renal transplant recipients that have been made with the classical D/ND classification, we aimed to analyze daily blood pressure rhythm with two mathematical related modeling methods, in order to achieve a better understanding of the nature of daily alterations in these patients: the double-logistic and the Cosinor methods. The first one, particularly, allowed the independent analysis of ascending and descending transitional periods. It was interesting to find that, despite what has been traditionally described with the D/ND classification, renal transplanted patients have blunted daily rhythms only for SAP, but did have consistent disruptions in waveform-related parameters such as time of transitional stages, and time of peak of the variation (depending on the method employed).

The wider distribution along the 24-h of the times of SAP and MAP ascending, and SAP, DAP, and MAP descending transitional stages in renal transplant recipients, as well as the slower ascending slope in MAP, clearly suggest a disruption in the mechanisms that rule the rise and decrease of blood pressure in kidney recipients. Some of the patients (as the one depicted in Figure [1](#F1){ref-type="fig"}) exhibited a clear inversion of temporal parameters of blood pressure. There are evidences of the compromise of the sympathetic nervous system in the normal regulation of the morning rise in blood pressure (Panza et al., [@B28]), and little is known about the mechanisms involved in the evening decline, even whether it is an active or a passive process. In renal transplant recipients, CsA has been particularly involved with sympathetic disturbances that induce a rise in blood pressure levels (Textor et al., [@B37]; Curtis, [@B5]), suggesting an active role of pharmacological treatment in disruptions in transitional stages. We could not find, however, any association of the waveform-related parameters with immunosuppressive treatment or any other pharmacological or physiological characteristics of patients. In particular, we found no association regarding hypertensive status; however, since hypertension is an important factor influencing blood pressure rhythm, additional studies should consider its role in more detail. Moreover, since neurohormonal factors (such as cortisol and renin secretion) influence blood pressure by several different mechanisms -- some of which are sleep-dependent, its role in circadian disruption in renal transplant recipients should be acknowledged in more detail. It should be stated that the number of patients evaluated in this study could represent a limitation for the analysis, and might have masked an effect of medication or hypertensive status on blood pressure variation. Larger studies concerning the relevance of these cues need to be performed

The presence of higher plateaus in renal transplant recipients is in accordance with previous descriptions of an increased rate of hypertensive status in renal transplant recipients (Textor et al., [@B37]; Curtis, [@B5]). Hypertension has also been associated to alterations in blood pressure rhythms, in particular with phase-related changes (Iantorno et al., [@B15]; Perez-Lloret et al., [@B30]). It is important to note that although both groups were matched by the average of the 24-h MAP, the comparisons of rhythmic parameters have been performed among patients with statistically significant daily rhythm, regardless of the initial matching protocol, so these differences are indeed representative of the changes present in the transplant recipient group.

In the case of the amplitude, we expected it to be reduced in kidney recipients, since the classical description of lower differences between day and night periods with the D/ND classification; however, no differences could be found between groups in our work. These results are in accordance with our finding that phase-related changes are the most consistent disruptions in kidney recipients.

Although the control group analyzed in this work differs in many aspects from the renal transplant group (which represents an organ replacement situation after a long time with an end-stage illness), albeit being matched for sex, age, and the average of 24 h MBP, these phase-related disruptions in the daily rhythm of blood pressure in transplanted individuals, taken together with the evidence of sleep disturbance (Neuhaus et al., [@B27]; Kemper et al., [@B20]), support the hypothesis of a weaker activity of the biological clock; moreover, the nature of these time-related disarrangements (wide distribution of time of ascending and descending blood pressure) can be explained as a blunted daily synchronization of endogenous rhythms to environmental cues. Supporting this hypothesis is the fact that the daily rhythm of blood pressure has a clear endogenous influence as described in its early morning rise (i.e., before waking time), its persistence in constant conditions, and its abolition after lesions of the hypothalamic suprachiasmatic nuclei (the central mammalian biological clock) (Halberg et al., [@B9]; Degaute et al., [@B6]; Portaluppi et al., [@B31]; Witte et al., [@B40]).

It is tempting to speculate that at least some of the changes exhibited in the renal transplant patients are related to their immune suppressant treatment. In our laboratory, we found not only the presence of calcineurin (the target of CsA and FK506) in the suprachiasmatic nuclei, but also that rodents treated with these immune suppressants have modifications in the activity of the circadian clock, as measured by locomotor activity rhythms, and a weaker synchronization to light stimuli (which resembles daily synchronization of the biological clock to day/night environmental cycle) (Katz et al., [@B19]). Indeed, it has been described that calcineurin inhibitors are capable of modifying electrical activity in the suprachiasmatic nuclei (Fukunaga et al., [@B7]). However, the lack of a clear association between circadian disruption and pharmacological treatment suggests that other mechanisms might be responsible for blood pressure rhythms alterations in renal transplant recipients. Notwithstanding, additional research is needed to determine the effect of clinical drugs on blood pressure variations, mainly because of the large list of factors that can influence this variable (Degaute et al., [@B6]; Lusardi et al., [@B23]; Portaluppi et al., [@B31]; Brandenberger et al., [@B2]).

As we have shown in this study, the double-logistic method allows a detailed analysis of the kinetics of BP rhythms, which could be useful to hypothesize about specific mechanisms related to the rise and decline in this parameter. There may be many cases were the D/ND classification is a more effective tool in BP analysis; indeed, other mathematical regression models could also be relevant for this analysis (Chau et al., [@B3]; Degaute et al., [@B6]; Idema et al., [@B16]; Stanton et al., [@B34]). A comparative analysis in larger populations among different methods is mandatory in order to determine which is the best descriptor of the variation, in terms of biological and clinical relevant parameters like prediction of morbidity. Another limitation of our study is the lack of repeated measures (\>24 h recording) in each individual, which could avoid hazardous collection of disarranged data due to intra-individual day by day variation. However the inter-individual reproducibility of shifted acrophase supports this finding. An additional limitation of the study is the lack of information concerning sleep performance in the population analyzed, since sleep disruption exerts an important influence on blood pressure (Chervin and Guilleminault, [@B4]; Lusardi et al., [@B23]). We can, however, discard sleep apnea on the basis of an initial questionnaire to patients and family regarding specific signs during the night.

In conclusion, the non-symmetrical double-logistic fitting and the Cosinor methods allowed us to get a more detailed description of disruptions occurring in blood pressure daily variations in renal transplant recipients. These analyses indicate that a phase-related disturbance occurs in these patients, rather than a complete loss of circadian variation. The traditional classification between dippers and non-dippers clearly differs from other chronobiological types of analysis when defining significant daily rhythmicity. The results found in this analysis have important clinical implications, which should be taken into account for predictive and therapeutic actions in kidney transplantation.
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